share_log
Breakings ·  Nov 20 16:55

RBC Capital: Raised the target price of gilead sciences from $81 to $84, maintaining a 'in line with the market' rating.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment